Syntis Bio Launches, Focusing On Oral Obesity Drugs And Rare Diseases

 
• By Jessica Merrill
  
intestine
Syntis bio is developing drugs for obesity • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Start-Ups & SMEs

More from Business